Quick Answer
AbbVie Inc. reported Total Assets of $133.96 billion for fiscal year 2025.
AbbVie Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $133.96B | -0.9% |
| 2024 | $135.16B | +0.3% |
| 2023 | $134.71B | -2.9% |
| 2022 | $138.81B | -5.3% |
| 2021 | $146.53B | -2.7% |
| 2020 | $150.56B | +69.0% |
| 2019 | $89.11B | +50.1% |
| 2018 | $59.35B | -16.2% |
| 2017 | $70.79B | +7.1% |
| 2016 | $66.10B | +24.6% |
| 2015 | $53.05B | +92.8% |
| 2014 | $27.51B | -5.8% |
| 2013 | $29.20B | +8.1% |
| 2012 | $27.01B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $133.90B | -6.6% | -2.4% |
| June 30, 2025 | $137.18B | -3.4% | +0.7% |
| March 31, 2025 | $136.16B | -8.5% | +0.7% |
| December 31, 2024 | $135.16B | +0.3% | -5.8% |
| September 30, 2024 | $143.42B | +5.3% | +1.0% |
| June 30, 2024 | $141.94B | +4.9% | -4.7% |
| March 31, 2024 | $148.87B | +10.7% | +10.5% |
| December 31, 2023 | $134.71B | -2.9% | -1.1% |
- AbbVie Inc. showed a decrease of -0.9% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, AbbVie Inc.’s total assets has grown by 396.0% (from $27.01 billion to $133.96 billion).
- The most recent figure is from AbbVie Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: